methylprednisolone has been researched along with Cancer of Pelvis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lang, JA; Loiudice, TA | 1 |
Ariño, VL; Bosch, V; Cañellas, D | 1 |
Amiot, L; Caulet-Maugendre, S; Diebold, J; Drénou, B; Fardel, O; Fauchet, R; Lamy, T; Le Prisé, PY; Sasportes, M | 1 |
1 trial(s) available for methylprednisolone and Cancer of Pelvis
Article | Year |
---|---|
Treatment of radiation enteritis: a comparison study.
Topics: Abdominal Neoplasms; Aged; Enteral Nutrition; Enteritis; Female; Humans; Male; Methylprednisolone; Middle Aged; Nitrogen; Parenteral Nutrition, Total; Pelvic Neoplasms; Radiation Injuries; Radiography; Random Allocation; Serum Albumin | 1983 |
2 other study(ies) available for methylprednisolone and Cancer of Pelvis
Article | Year |
---|---|
[A case of plasmocytoma treated with local injection of methylprednisolone acetate].
Topics: Humans; Injections; Male; Methylprednisolone; Middle Aged; Pelvic Neoplasms; Plasmacytoma | 1981 |
CD3- CD56+ non-Hodgkin's lymphomas with an aggressive behavior related to multidrug resistance.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bone Marrow Transplantation; CD3 Complex; CD56 Antigen; Cell Nucleus; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Fatal Outcome; Female; Femoral Neoplasms; Herpesvirus 4, Human; Humans; Idarubicin; Immunophenotyping; Killer Cells, Natural; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Methylprednisolone; Neoplasm Invasiveness; Neoplasm Proteins; Neoplastic Stem Cells; Pelvic Neoplasms; Prednisone; Quinine; Vincristine | 1997 |